Chronic Spontaneous Urticaria: Pathogenesis and Treatment Considerations.

about

Clinical Course of Chronic Spontaneous Urticaria in the Korean Adult Population.

P2860

Q47105217-02BC180F-A401-4DFD-A6A1-CECBA51337DB

P2860

Chronic Spontaneous Urticaria: Pathogenesis and Treatment Considerations.

Item

http://www.wikidata.org/entity/Q42736757

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Chronic Spontaneous Urticaria: Pathogenesis and Treatment Considerations.

@en

Chronic Spontaneous Urticaria: Pathogenesis and Treatment Considerations.

@nl

type

Item

label

Chronic Spontaneous Urticaria: Pathogenesis and Treatment Considerations.

@en

Chronic Spontaneous Urticaria: Pathogenesis and Treatment Considerations.

@nl

prefLabel

Chronic Spontaneous Urticaria: Pathogenesis and Treatment Considerations.

@en

Chronic Spontaneous Urticaria: Pathogenesis and Treatment Considerations.

@nl

P1476

Chronic Spontaneous Urticaria: Pathogenesis and Treatment Considerations.

@en

P2093

Allen P Kaplan

http://www.w3.org/2001/XMLSchema#string

P2860

Efficacy of leukotriene receptor antagonist in chronic urticaria. A double-blind, placebo-controlled comparison of treatment with montelukast and cetirizine in patients with chronic urticaria with intolerance to food additive and/or acetylsalicylic

Omalizumab for the treatment of chronic idiopathic or spontaneous urticaria.

The leukotriene receptor antagonist montelukast in the treatment of chronic idiopathic urticaria: a single-blind, placebo-controlled, crossover clinical study.

Double-blind placebo-controlled trial of dapsone in antihistamine refractory chronic idiopathic urticaria.

A randomized, placebo-controlled, dose-ranging study of single-dose omalizumab in patients with H1-antihistamine-refractory chronic idiopathic urticaria.

Omalizumab in patients with symptomatic chronic idiopathic/spontaneous urticaria despite standard combination therapy.

Successful treatment of recalcitrant chronic idiopathic urticaria with sulfasalazine.

Efficacy and safety of omalizumab in patients with chronic idiopathic/spontaneous urticaria who remain symptomatic on H1 antihistamines: a randomized, placebo-controlled study.

Treatment of chronic autoimmune urticaria with omalizumab.

Pathogenesis of chronic urticaria.

P304

477-482

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4168/AAIR.2017.9.6.477

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28913986

http://www.w3.org/2001/XMLSchema#string

P932

5603475

http://www.w3.org/2001/XMLSchema#string

Chronic Spontaneous Urticaria: Pathogenesis and Treatment Considerations.

about

P2860

P2860

Chronic Spontaneous Urticaria: Pathogenesis and Treatment Considerations.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932